These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37981651)

  • 1. Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies.
    Omidi F; Zangiabadian M; Shahidi Bonjar AH; Nasiri MJ; Sarmastzadeh T
    Sci Rep; 2023 Nov; 13(1):20235. PubMed ID: 37981651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between Combined Influenza and Pneumococcal Pneumonia Vaccination and Cardiovascular Outcomes.
    Ma J; Mena M; Mandania RA; Ghosh A; Dodoo C; Dwivedi AK; Mukherjee D
    Cardiology; 2021; 146(6):772-780. PubMed ID: 34521082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.
    Udell JA; Zawi R; Bhatt DL; Keshtkar-Jahromi M; Gaughran F; Phrommintikul A; Ciszewski A; Vakili H; Hoffman EB; Farkouh ME; Cannon CP
    JAMA; 2013 Oct; 310(16):1711-20. PubMed ID: 24150467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Between Cardiovascular Protection and Influenza Vaccination.
    Ngwudike CJ; Villalobos A
    Curr Cardiol Rep; 2023 Jun; 25(6):571-576. PubMed ID: 37058200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines for preventing influenza in healthy children.
    Jefferson T; Rivetti A; Di Pietrantonj C; Demicheli V
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004879. PubMed ID: 29388195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis.
    Gupta C; Sachdeva A; Khamar J; Bu C; Bartoszko J; Loeb M
    Vaccine; 2022 May; 40(25):3433-3443. PubMed ID: 35562195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial.
    Loeb M; Roy A; Dokainish H; Dans A; Palileo-Villanueva LM; Karaye K; Zhu J; Liang Y; Goma F; Damasceno A; Alhabib KF; Yonga G; Mondo C; Almahmeed W; Al Mulla A; Thanabalan V; Rao-Melacini P; Grinvalds A; McCready T; Bangdiwala SI; Yusuf S;
    Lancet Glob Health; 2022 Dec; 10(12):e1835-e1844. PubMed ID: 36400089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study.
    Sen A; Bakken IJ; Govatsmark RES; Varmdal T; Bønaa KH; Mukamal KJ; Håberg SE; Janszky I
    BMC Cardiovasc Disord; 2021 Jan; 21(1):31. PubMed ID: 33435871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis.
    Behrouzi B; Bhatt DL; Cannon CP; Vardeny O; Lee DS; Solomon SD; Udell JA
    JAMA Netw Open; 2022 Apr; 5(4):e228873. PubMed ID: 35486404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis.
    Maniar YM; Al-Abdouh A; Michos ED
    Curr Cardiol Rep; 2022 Oct; 24(10):1327-1335. PubMed ID: 35876953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of influenza vaccination on cardiovascular disease.
    Pérez-Rubio A; San Román JA; Eiros Bouza JM
    Med Clin (Barc); 2021 Jul; 157(1):22-32. PubMed ID: 33832764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for preventing influenza in the elderly.
    Demicheli V; Jefferson T; Di Pietrantonj C; Ferroni E; Thorning S; Thomas RE; Rivetti A
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004876. PubMed ID: 29388197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza Vaccination as Prevention Therapy for Stable Coronary Artery Disease and Acute Coronary Syndrome: A Meta-Analysis of Randomized Trials.
    Barbetta LMDS; Correia ETO; Gismondi RAOC; Mesquita ET
    Am J Med; 2023 May; 136(5):466-475. PubMed ID: 36809811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Yedlapati SH; Khan SU; Talluri S; Lone AN; Khan MZ; Khan MS; Navar AM; Gulati M; Johnson H; Baum S; Michos ED
    J Am Heart Assoc; 2021 Mar; 10(6):e019636. PubMed ID: 33719496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis.
    Marra F; Zhang A; Gillman E; Bessai K; Parhar K; Vadlamudi NK
    Int J Infect Dis; 2020 Oct; 99():204-213. PubMed ID: 32735953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series.
    Caldeira D; Rodrigues B; David C; Costa J; Pinto FJ; Ferreira JJ
    Expert Rev Vaccines; 2019 Nov; 18(11):1211-1217. PubMed ID: 31693865
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction.
    Hebsur S; Vakil E; Oetgen WJ; Kumar PN; Lazarous DF
    Rev Cardiovasc Med; 2014; 15(2):168-75. PubMed ID: 25051134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.